期刊文献+

米索前列醇不同给药方式联合宫腔吸引管在剖宫产术后无痛人流中的应用 被引量:12

Adhibition of Misoprostol Combined with Palace Cavity Attraction Tube in the Treatment of Painless Abortion after Cesarean Section
原文传递
导出
摘要 目的:探讨米索前列醇不同给药方式联合宫腔吸引管在剖宫产术后无痛人流中的应用。方法:214例剖宫产术后无痛人流患者随机分为A组(71例)、B组(71例)、C组(72例)。所有患者均给予常规静脉麻醉后,A组患者术前2 h给予米索前列醇0.6mg,口服;B组患者术前3 h给予米索前列醇片0.2 mg,研粉后置入阴道后穹窿;C组患者不给予相关药物。各组患者均使用一次性宫腔吸引管。观察各组患者的镇静效果、宫颈扩张效果、手术时间、术中出血量、苏醒时间、异丙酚用量、并发症发生情况及不良反应发生情况。结果:A组患者手术时间、术中出血量<B组<C组,差异有统计学意义(P>0.05),A组患者苏醒时间、异丙酚用量<B、C组,差异均有统计学意义(P<0.05),但B、C两组间比较差异无统计学意义(P>0.05);A、B组患者镇静、宫颈扩张总有效率显著高于C组,差异有统计学意义(P<0.05),但A、B两组间比较差异无统计学意义(P>0.05);A组患者并发症发生率<B组<C组,差异有统计学意义(P<0.05)。各组患者不良反应发生率比较,差异无统计学意义(P>0.05);结论 :口服或阴道给予米索前列醇联合宫腔吸引管治疗剖宫产术后无痛人流的疗效和安全性均相当,但口服给药可减少麻醉药物用量,减少术中出血量,缩短手术时间。 OBJECTIVE:To study the adhibition of misoprostol combined with palace cavity attraction tube in the treatment of painless abortion after cesarean section. METHODS:214 patients who received painless abortion after cesarean section were randomly divided into group A(71 case),group B(71 case)and group C(72 case). After all patients were given conventional intravenous anesthesia,Group A was given misoprostol 0.6 mg for oral administration in preoperative 2 h. Group B was given Misoprostol tablet 0.2 mg abrasive powder put in posterior fornix in preoperative 3 h. Group C did not give any drugs. All the groups used disposable suction curettage tube. The efficacies of sedation and cervical dilatation,operation time,intraoperative blood loss,recovery time,dosage of propofol and incidences of complications and adverse reactions in the 3 groups were observed. RESULTS:The operation time,intraoperative blood loss in group A were lower than group B and lower than group C,the differences were statistically significant(P〈0.05);recovery time and dosage of propofol in group A were lower than group B and C,the differences were statistically significant(P〈0.05),howerer,there was no significant difference between group B and C(P〉0.05). The total effective rates of sedation and cervical dilatation in group A and B were significantly higher than group C,and the difference was statistically significant(P〈0.05),however,there was no significant difference between group A and B(P〉0.05). The incidence of complications in group A was lower than group B and lower than group C,and the difference was statistically significant(P〈0.05).There was no significant difference in the incidence of adverse reactions among 3 groups(P〉0.05). CONCLUSIONS:The efficiency and safety of misoprostol for oral administration or medicated vaginal suppository combined with palace cavity attraction tube in the treatment of painless abortion after cesarean section is similar,but oral administration can reduce the dosage of anesthetics,operation time and smaller intraoperative blood loss volume.
出处 《中国药房》 CAS 北大核心 2015年第33期4631-4633,共3页 China Pharmacy
关键词 米索前列醇 无痛人流 宫腔吸引管 剖宫产 Misoprostol Painless abortion Palace cavity attraction tube Cesarean section
  • 相关文献

参考文献15

  • 1Agaoglu AR, Asian S, Emre B, et al. Clinical evaluationof different applications of misoprostol and aglepristone for induction of abortion in bitches[J]. Theriogenology, 2014,81(7) :947.
  • 2Jha T, Das A, Bhattacharya AR, et al. Comparison of tw- o doses of oral misoprostol with one, after mifepristone in early abortion[J]. J Indian Med Assoc, 2013, 111 ( 12 ) : 826.
  • 3Quan ZF, Tian M, Chi P, et al. Effective analgesic dose of dexamethasone after painless abortion[J]. Int J Clin Exp Med,2014,7(8) :2 144.
  • 4陆丽娟,周燕,雷美珍.米索前列醇在早孕无痛人工流产中的应用[J].中国医药指南,2013,11(12):658-659. 被引量:1
  • 5Dickinson JE, Jennings BG, Doherty DA. Mifepristone and oral, vaginal, or sublingual misoprostol for sec- ond-trimester abortion: a randomized controlled trial[J]. Obstet Gynecol,2014,123 ( 6 ) :1 162.
  • 6Sak ME, Soydinc HE, Evsen MS, et al. Which factors may influence the duration of misoprostol-induced abor- tion in the second trimester?[J]. Clin Exp Obstet Gynecol, 2013,40(3) : 356.
  • 7李沁,陈继明,高红艳,郭彩霞.不同人流方式在初孕妇女无痛人流的对比分析[J].中国妇幼健康研究,2012,23(4):495-498. 被引量:8
  • 8Kumar R. Misoprostol and the politics of abortion in Sri Lanka[J]. Reprod Health Matters, 2012,20(40):166.
  • 9胡晓冬,陈茹.丙泊酚复合舒芬太尼用于无痛人流的临床应用[J].中国实用医药,2012,7(8):184-185. 被引量:6
  • 10Bhadra B, Deb T. Role of oral misoprostol for treatment of incomplete abortion[J]. J lndian Med Assoc, 2013,111 (10) : 689.

二级参考文献32

共引文献21

同被引文献79

引证文献12

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部